| 000 | 01318 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513084503.0 | ||
| 264 | 0 | _c19960301 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuzel, T M | |
| 245 | 0 | 0 |
_aPhase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma. _h[electronic resource] |
| 260 |
_bBlood _cFeb 1996 |
||
| 300 |
_a906-11 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCladribine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycosis Fungoides _xdrug therapy |
| 650 | 0 | 4 |
_aOpportunistic Infections _xetiology |
| 650 | 0 | 4 |
_aSezary Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHurria, A | |
| 700 | 1 | _aSamuelson, E | |
| 700 | 1 | _aTallman, M S | |
| 700 | 1 | _aRoenigk, H H | |
| 700 | 1 | _aRademaker, A W | |
| 700 | 1 | _aRosen, S T | |
| 773 | 0 |
_tBlood _gvol. 87 _gno. 3 _gp. 906-11 |
|
| 999 |
_c8562033 _d8562033 |
||